← Classic psychedelics

Psilocybin

The principal psychedelic in psilocybin mushrooms

A familiar world, seen and felt in unfamiliar ways.

C₁₂H₁₇N₂O₄PView molecular structure

Psilocybin occurs in many species of psychedelic mushrooms. The body converts it into psilocin, which produces most of its effects.

Its place in contemporary culture spans personal exploration, Indigenous traditions and clinical research. These settings share a compound, but not necessarily the same intentions or experience.

Psilocybin at a glance

Family
Tryptamines
Type
Classic psychedelic
Primary target
5-HT2A, through psilocin
Onset (oral)
Usually 20–60 minutes
Duration (oral)
About 4–6 hours
Origin
Certain mushrooms

What is Psilocybin?

Psilocybin is a naturally occurring tryptamine. After conversion to psilocin, it acts at serotonin receptors, particularly 5-HT2A, changing how perception, emotion and thought are organised.

A mushroom is not a standardised quantity of psilocybin. Species, individual specimens and storage can all affect its composition. Research with measured psilocybin is therefore different from research with whole mushrooms.

The Psilocybin experience

Sensory effects

Colours and textures may become unusually vivid. Patterns can seem to breathe, and closed-eye imagery may develop into intricate shapes or scenes.

Music can feel more layered or emotionally absorbing. Some people describe synaesthesia, such as sounds seeming to have colour; these temporary experiences need not resemble lifelong synaesthesia.

Body sensations

The body may feel light, heavy or unusually sensitive. Nausea and other physical discomfort can occur alongside pleasant sensations, and bodily feelings may change during the experience.

Headspace

Thoughts often become more associative. Memories, relationships and familiar habits can acquire new significance. Laughter, tenderness and connection may alternate with sadness, uncertainty or fear.

Self, time and space

Time may feel stretched or difficult to follow. At greater intensity, the boundary between self and surroundings can soften, sometimes described as ego dissolution. A powerful feeling of meaning is not the same as a factual conclusion.

History and culture

Psychedelic mushrooms have longstanding ceremonial roles among Indigenous peoples in Mexico. These are living traditions, with their own languages, practices and meanings.

Albert Hofmann isolated psilocybin and psilocin in the 1950s. Wider Western interest brought research and popular attention, but also disruption and appropriation of the communities whose practices attracted that attention.

Research and uses

Clinical studies have investigated psilocybin with psychological support for depression and other conditions. Results have encouraged larger trials, but outcomes depend on the people studied, the support provided and how improvement is measured.

Research also explores changes in perception and brain activity. These studies do not establish that every mushroom experience is therapeutic, or that a meaningful experience necessarily produces lasting benefit.

Risks and considerations

Anxiety, confusion, nausea and temporary increases in blood pressure can occur. Altered judgement can create a risk of injury, and particular mental-health vulnerabilities may make the experience less predictable.

Whole mushrooms introduce an additional issue: misidentification can cause serious poisoning. Persistent perceptual disturbances are reported with psychedelics, although their frequency and causes remain uncertain.

FAQ

Is psilocybin the same as psilocin?

No. They are closely related; psilocybin is converted into psilocin in the body.

Does natural mean safer?

No. Origin does not determine safety, and mushroom potency is variable.

Is it always a spiritual experience?

No. People describe many kinds of experience, including ordinary, playful, difficult or confusing ones.

Sources
  1. EUDA: Hallucinogenic mushrooms
  2. NIH: Psychedelic and dissociative drugs
  3. PubChem: Psilocybin molecular identity
  4. Controlled comparison of mescaline, LSD and psilocybin
  5. The chemical induction of synaesthesia